Medical specialties

Statement from the Chief Public Health Officer of Canada on May 15, 2021

Saturday, May 15, 2021 - 6:00pm

For students in particular, this has been a difficult and stressful school year for many, adapting to uncertainty and changes.

Key Points: 
  • For students in particular, this has been a difficult and stressful school year for many, adapting to uncertainty and changes.
  • If you are struggling or having a difficult time know that there are options for resources and supports to help.
  • At the same time, the Public Health Agency of Canada is providing Canadians with regular updates on COVID-19 vaccines administered , vaccination coverage and ongoing monitoring of vaccine safety across the country.
  • Working together, Health Canada , the Public Health Agency of Canada , the National Advisory Committee on Immunization , Canada's Chief Medical Officers of Health and other health professionals across the country are closely monitoring vaccine safety , effectiveness and optimal use to adapt approaches.

Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21

Saturday, May 15, 2021 - 5:00pm

Using observed changes in LDL-C at week 12, researchers applied the CTT coefficient to calculate an estimated 10-year cardiovascular event relative risk reduction rate.

Key Points: 
  • Using observed changes in LDL-C at week 12, researchers applied the CTT coefficient to calculate an estimated 10-year cardiovascular event relative risk reduction rate.
  • In these studies, NEXLETOL provided an average of 18% placebo-corrected LDL-C lowering at week 12 when used with moderate or high-intensity statins.
  • The effect of NEXLETOL on cardiovascular morbidity and mortality has not been determined.\nElevations in serum uric acid have occurred.
  • \xe2\x80\x9cRationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance.\xe2\x80\x9d American Heart Journal.

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology’s 70th Annual

Saturday, May 15, 2021 - 1:00pm

\xe2\x80\x9cThe potential benefit of increased serum EPA levels in reducing the composite of cardiovascular death or new heart failure requiring hospitalization in at-risk patients is a novel finding for icosapent ethyl and requires further prospective validation.

Key Points: 
  • \xe2\x80\x9cThe potential benefit of increased serum EPA levels in reducing the composite of cardiovascular death or new heart failure requiring hospitalization in at-risk patients is a novel finding for icosapent ethyl and requires further prospective validation.
  • New heart failure and new heart failure requiring hospitalization were prespecified tertiary endpoints and were not significant in the overall patient population.
  • \xe2\x80\x9cHeart failure, in particular, devastates patients, their families and economies with significant direct costs and societal impact.
  • ET to further discuss these and other VASCEPA-related findings presented during ACC.21, with replay available for a period of 14 days.

New Diagnostic Technology Showcased During Osteoporosis Awareness Month

Friday, May 14, 2021 - 10:54pm

"The portability and ease of use of REMS technology means screening can begin earlier, better positioning patients and their health care providers to take meaningful steps to prevent the onset of osteoporosis rather than to treat the disease once fractures begin to impact quality of life.

Key Points: 
  • "The portability and ease of use of REMS technology means screening can begin earlier, better positioning patients and their health care providers to take meaningful steps to prevent the onset of osteoporosis rather than to treat the disease once fractures begin to impact quality of life.
  • "\nMore than half of Americans age 50 and older have a high-risk of bone fracture, making osteoporosis and osteopenia an urgent public health issue.
  • It is especially prominent in women, as pregnancy and menopause can cause bone density loss.
  • Portable, diagnostic, radiation-free bone health densitometer - a safe, accurate, and cost-effective medical device elevating bone health awareness and treatment to mainstream medical care.

ProfNet Expert Alerts for May 14, 2021

Friday, May 14, 2021 - 9:00pm

I help families make sure their home air is clean and free of pollutants and pathogens.

Key Points: 
  • I help families make sure their home air is clean and free of pollutants and pathogens.
  • "\nCaroline can share advice on how to keep homes healthy and virus free - especially during high allergy seasons and under the cloak of the pandemic.
  • Caroline has developed many unique testing methods and products for residential consumers to evaluate their homes and maintain healthy environments economically.
  • She spends substantial time investigating new testing methods and products that will aid her clients with healthier living.

Researchers Show How COVID-19 Virus Triggers Immune Signaling "Storm"

Friday, May 14, 2021 - 7:21pm

The virus evolved to have a protein spike that snags ACE2 as the first step in invading human lung cells, where the virus multiplies.

Key Points: 
  • The virus evolved to have a protein spike that snags ACE2 as the first step in invading human lung cells, where the virus multiplies.
  • Accordingly, all approved COVID-19 antiviral drugs and vaccines work by interfering with, or protecting against, this viral spike/ACE2 interaction.\nMounting evidence, however, suggests that the virus also interacts directly with human immune cells, which have little ACE2 on their surfaces.
  • Five were C-type lectins, carbohydrate-binding protein units with many biological functions, including in immune defenses.
  • Nanobodies are smaller derivatives of antibodies, immune proteins that form a surveillance system by recognizing invading microbes.

Sciton U.K. Announces Central London Flagship Showroom and Training Centre in Partnership with Skin Group International Ltd (SGI)

Friday, May 14, 2021 - 7:08pm

"Harley Street in London represents an area well known for excellence in medical aesthetics.

Key Points: 
  • "Harley Street in London represents an area well known for excellence in medical aesthetics.
  • Sciton offers aesthetic and medical devices for women\'s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction.
  • Sciton operates on a worldwide basis with direct sales teams in the United States, Canada, Australia, United Kingdom, Ireland, Japan and distributor partners in more than 45 countries.
  • For more information, and a complete listing of Sciton systems, visit www.sciton.com .\n'

Outlook on the Medical Enzyme Technology Global Market to 2028 - Rising Production of Biopharmaceutical Products Presents Opportunities - ResearchAndMarkets.com

Friday, May 14, 2021 - 6:00pm

Abnormalities in enzyme metabolism system leads to many metabolic diseases.

Key Points: 
  • Abnormalities in enzyme metabolism system leads to many metabolic diseases.
  • Many enzymes are being widely used in the clinical examination as a specific disease marker.
  • Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, and neurodegenerative disorders.
  • However, the market for normothermic machine perfusion is estimated to grow at a higher CAGR of 4.4% during the forecast period.\nThe medical enzyme technology market, by application, is segmented into disease treatment, diagnostic tools, biomedical research, and others.

Global Joint Pain Injection Market (2021 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Friday, May 14, 2021 - 5:38pm

However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.

Key Points: 
  • However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.
  • Sports injuries are caused due to direct impact or due to the application of force that is larger than the body part can withstand.
  • Thus, the growing number of sport injuries is boosting the demand for joint pain injections.\nBased on joint type, the joint pain injection market is segmented into knee, shoulder and elbow, hip, foot and ankle, and others.
  • In 2020, the knee joint type segment accounted for the largest share of the market.

Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy

Friday, May 14, 2021 - 5:45pm

(Nasdaq: VCYT) announced today new data demonstrating the ability of the Percepta\xc2\xae Genomic Atlas to detect alterations that may inform lung cancer treatment decisions for patients from the same small biopsy that was used for diagnosis.

Key Points: 
  • (Nasdaq: VCYT) announced today new data demonstrating the ability of the Percepta\xc2\xae Genomic Atlas to detect alterations that may inform lung cancer treatment decisions for patients from the same small biopsy that was used for diagnosis.
  • The test uses targeted DNA and whole-transcriptome RNA sequencing to detect alterations in more than 50 genes known to be present in lung cancer.
  • The company\xe2\x80\x99s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development.
  • Examples of forward-looking statements include, among others, statements regarding the ability of the Percepta Genomic Atlas to accurately detect known lung-cancer gene variants and help to guide treatment with targeted therapies.